Lucid Diagnostics Inc. (LUCD) Tops Q3 EPS by 7c

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $80 thousand versus the consensus estimate of $431.38 thousand.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• Verizon to cut 3,000 jobs as it shifts stores to franchises
• After-Hours Stock Movers: NFLX, ISRG, KO, AA, RGNX
• Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue